GO:0046115 guanosine catabolic process: Purine Turnover Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046115 (guanosine catabolic process) describes the biochemical breakdown of guanosine and related guanine-containing nucleosides into free guanine and/or xanthine, feeding into purine salvage and urate production.
• The process is central to purine homeostasis and is linked to neuroprotection, since purine nucleosides such as guanosine and inosine exert trophic and protective effects in the nervous system.
• Guanosine catabolism intersects with RNA modification pathways because modified guanosines (e.g., 7-methylguanosine, N7-methylguanosine) are generated and turned over on tRNA and mRNA caps.
• Dysregulated guanosine metabolism has been implicated in cancer progression, where N7-methylguanosine tRNA modification supports mitochondrial oxidative phosphorylation in gastric cancer.
• Oxidative damage to guanosine derivatives, such as HOCl-mediated oxidation of 8-oxo-guanosine, produces abasic sites that can be mapped to study RNA damage and repair.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of guanosine catabolic enzymes in disease and neurobiology.
Description
Guanosine catabolic process (GO:0046115) is the set of biochemical reactions that degrade guanosine and related guanine-containing nucleosides into simpler purine intermediates. This process is essential for maintaining purine balance, recycling nucleosides, and generating metabolites that influence cellular signaling and neuroprotection. In the nervous system, purine nucleosides such as guanosine and inosine have been shown to promote neuroregeneration and neuroprotection, highlighting the physiological importance of their catabolism. Beyond neurobiology, guanosine catabolism is intertwined with RNA modification pathways, as modified guanosines on tRNA and mRNA caps are dynamically synthesized and removed. For example, 7-methylguanosine modifications in tRNA are critical for translation fidelity and are subject to turnover, while mRNA cap methylation regulates transcript stability and translation. Understanding guanosine catabolic process therefore provides a window into purine metabolism, RNA modification dynamics, and disease mechanisms ranging from cancer to neurodegeneration.
guanosine catabolic process At A Glance
| GO ID | GO:0046115 |
|---|---|
| GO term | guanosine catabolic process |
| Ontology | biological_process |
| Synonym | guanosine breakdown; guanosine catabolism; guanosine degradation; guanosine phosphorolysis |
| Major function | Breakdown of guanosine and guanine-containing nucleosides into purine catabolites |
| Definition source | QuickGO definition: chemical reactions and pathways resulting in the breakdown of guanine, guanine riboside, a nucleoside with a wide species distribution |
| Related pathways | Purine metabolism, nucleoside salvage, RNA modification turnover |
| Disease relevance | Cancer, neurodegeneration, purine metabolism disorders |
| Research methods | CRISPR KO/knock-in, RNA-seq, Ribo-seq, metabolomics, proteomics |
What Is GO:0046115?
According to the Gene Ontology, guanosine catabolic process (GO:0046115) is defined as the chemical reactions and pathways resulting in the breakdown of guanine, guanine riboside, a nucleoside with a wide species distribution. In simpler terms, it covers the enzymatic steps that convert guanosine (guanine riboside) and related guanine-containing molecules into downstream purine catabolites. This process is a biological_process and includes synonyms such as guanosine breakdown, guanosine catabolism, guanosine degradation, and guanosine phosphorolysis.
Why Is guanosine catabolic process Important in Cell Biology?
Guanosine catabolic process is important because it controls the availability of guanosine and guanine derivatives that participate in RNA modification, energy metabolism, and neuroprotection. Purine nucleosides such as guanosine have been shown to promote neuroregeneration and neuroprotection, and their catabolism determines the balance between signaling and degradation. In cancer, N7-methylguanosine tRNA modification, which depends on guanosine metabolism, promotes gastric cancer progression by activating mitochondrial oxidative phosphorylation. Additionally, oxidative damage to guanosine derivatives generates abasic sites that can be mapped to study RNA damage. Thus, understanding guanosine catabolism is critical for both basic purine biology and translational research.
• Maintains purine homeostasis by degrading excess guanosine and guanine nucleosides.
• Supports neuroprotection and neuroregeneration through controlled release of purine metabolites.
• Links to RNA modification pathways, including 7-methylguanosine and N7-methylguanosine turnover.
• Influences mRNA cap methylation and transcript stability via guanosine-derived metabolites.
• Contributes to oxidative RNA damage and abasic site formation from oxidized guanosine.
• Plays a role in cancer metabolism, as shown for N7-methylguanosine tRNA modification in gastric cancer.
• Provides targets for CRISPR-based functional studies of purine catabolic enzymes.
• Helps interpret frameshifting and translation fidelity defects linked to modified guanosines.
• Relevant to spliceosomal snRNP biology through shared nucleotide metabolism.
• Offers biomarkers and therapeutic entry points in purine-related diseases.
What Happens During guanosine catabolic process?
Substrate recognition and initial hydrolysis
In simple terms: The process starts when enzymes recognize guanosine and related guanine nucleosides and prepare them for breakdown.
Guanosine catabolic process begins with the recognition of guanosine (guanine riboside) and related guanine-containing nucleosides by catabolic enzymes. This step is essential for purine turnover and is part of the broader purine nucleoside metabolism that supports neuroregeneration and neuroprotection. The breakdown of guanine riboside is a key node because it determines whether guanosine is salvaged or degraded.
Phosphorolysis and nucleoside cleavage
In simple terms: Enzymes cut the sugar from the base, releasing guanine for further processing.
A central step in guanosine catabolism is phosphorolysis, where the glycosidic bond of guanosine is cleaved to release guanine and ribose-1-phosphate. This reaction is a classic purine nucleoside phosphorylase activity and is part of the guanosine phosphorolysis synonym for GO:0046115. Such cleavage is important for balancing purine pools and is linked to the neuroprotective effects of purine nucleosides.
Guanine deamination and xanthine formation
In simple terms: The released guanine is chemically modified and converted into xanthine, a step toward urate.
After guanine is released, it can be deaminated to xanthine, which is a precursor of uric acid. This step connects guanosine catabolic process to purine catabolism and oxidative stress pathways. Oxidative damage to guanosine derivatives, such as HOCl-oxidized 8-oxo-guanosine, can produce abasic sites that are relevant to RNA damage and repair. Thus, guanine deamination is both a metabolic and a quality-control step.
Turnover of modified guanosines
In simple terms: Modified guanosines on RNA are also broken down, linking catabolism to RNA modification cycles.
Guanosine catabolic process also intersects with the turnover of modified guanosines such as 7-methylguanosine and N7-methylguanosine. These modifications are found on tRNA and mRNA caps and are dynamically regulated. For example, N7-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation. Additionally, an RNA modification prevents extended codon-anticodon interactions from facilitating +1 frameshifting, showing how modified guanosines affect translation.
Integration with purine salvage and signaling
In simple terms: The breakdown products can be recycled or used as signals, depending on cellular needs.
The products of guanosine catabolism can enter purine salvage pathways or act as signaling molecules. Purine nucleosides such as guanosine and inosine have neuroprotective and neuroregenerative effects, so their catabolism must be tightly balanced. This integration ensures that guanosine catabolic process supports both metabolic homeostasis and intercellular signaling.
Key Genes Involved in GO:0046115 guanosine catabolic process
The following genes and proteins are experimentally or functionally linked to guanosine catabolic process and related purine/RNA modification pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PNP | Purine nucleoside phosphorylase; cleaves guanosine to guanine and ribose-1-phosphate | Core enzyme in guanosine phosphorolysis; target for purine metabolism studies |
| GDA | Guanine deaminase; converts guanine to xanthine | Links guanosine catabolism to urate production and oxidative stress |
| XDH | Xanthine dehydrogenase; oxidizes xanthine to uric acid | Downstream of guanosine catabolism; relevant to purine disorders |
| HPRT1 | Hypoxanthine-guanine phosphoribosyltransferase; salvage of guanine | Balances catabolism versus salvage of guanine |
| ADA | Adenosine deaminase; purine nucleoside metabolism | Indirectly affects guanosine pools and neuroprotection |
| ENT1 | Equilibrative nucleoside transporter; guanosine transport | Regulates substrate availability for catabolism |
| ENT2 | Equilibrative nucleoside transporter; nucleoside uptake | Modulates intracellular guanosine levels |
| CNT2 | Concentrative nucleoside transporter; purine nucleoside uptake | Affects guanosine catabolic flux |
| METTL1 | N7-methylguanosine tRNA methyltransferase | Generates modified guanosines that are turned over |
| WDR4 | Partner of METTL1 for N7-methylguanosine modification | Required for tRNA modification and cancer progression |
| RNMT | mRNA cap methyltransferase; adds 7-methylguanosine cap | Connects guanosine metabolism to mRNA stability |
| TGS1 | Trimethylguanosine synthase; modifies snRNA caps | Links guanosine derivatives to snRNP biogenesis |
| SDHAF4 | Mitochondrial oxidative phosphorylation assembly factor | Downstream effector of N7-methylguanosine in gastric cancer |
| NUDT | Nudix hydrolases; hydrolyze oxidized guanosine nucleotides | Relevant to oxidative RNA damage and abasic sites |
| OGG1 | 8-oxoguanine DNA glycosylase; repairs oxidized guanine | Connects guanosine oxidation to repair pathways |
| MTR | Methylthioadenosine phosphorylase; purine salvage | Indirectly affects guanosine catabolism |
| ATIC | Bifunctional purine biosynthesis enzyme | Balances purine synthesis and catabolism |
How Is guanosine catabolic process Regulated?
Guanosine catabolic process is regulated at multiple levels, including substrate availability, enzyme expression, and feedback from purine pools. Purine nucleoside transporters such as ENT1, ENT2, and CNT2 control the intracellular concentration of guanosine, thereby influencing catabolic flux. The activity of purine nucleoside phosphorylase and guanine deaminase can be modulated by cellular energy status and oxidative stress, as oxidized guanosine derivatives are processed by repair and catabolic enzymes. In cancer, N7-methylguanosine tRNA modification, which depends on METTL1/WDR4, promotes mitochondrial oxidative phosphorylation and gastric cancer progression, indicating that modified guanosine turnover is linked to metabolic regulation. Additionally, mRNA cap methylation by RNMT regulates transcript stability and translation, indirectly affecting guanosine nucleotide pools. These layers of regulation ensure that guanosine catabolism is coordinated with RNA modification, purine salvage, and neuroprotective signaling.
guanosine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| METTL1 | Gastric cancer progression via N7-methylguanosine tRNA modification | Knockout and overexpression in gastric cancer cell lines |
| WDR4 | Cancer metabolism and tRNA modification | Point mutation and knockout models |
| PNP | Purine metabolism disorders and neuroprotection | Knockout in neuronal cell models |
| GDA | Oxidative stress and urate production | Knock-in of catalytic mutants |
| RNMT | mRNA cap methylation and transcript stability | Overexpression and knockout in cancer cells |
Cancer metabolism and N7-methylguanosine
N7-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation. Because this modification is a guanosine derivative, its turnover is directly connected to guanosine catabolic process. Dysregulation of guanosine catabolism may therefore alter tRNA modification levels and mitochondrial metabolism in cancer cells.
Neurodegeneration and neuroprotection
Purine nucleosides such as guanosine and inosine have neuroprotective and neuroregenerative properties, and their catabolism determines the duration and intensity of these effects. Imbalances in guanosine catabolic process could reduce the availability of protective nucleosides, contributing to neurodegeneration. Thus, enzymes of guanosine catabolism are potential targets for neuroprotective strategies.
RNA damage and oxidative stress
Oxidative damage to guanosine derivatives, such as HOCl-oxidized 8-oxo-guanosine, generates abasic sites that are major RNA damage products. These lesions can interfere with translation and require repair or degradation. Guanosine catabolic process is therefore linked to RNA quality control and cellular stress responses.
Translation fidelity and frameshifting
Modified guanosines in tRNA influence codon-anticodon interactions and prevent +1 frameshifting. Defects in the turnover of these modified guanosines could impair translation fidelity. This connects guanosine catabolic process to ribosome function and protein synthesis.
From guanosine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PNP affect guanosine catabolism and neuroprotection? | CRISPR knockout in neuronal cell lines |
| Does METTL1-mediated N7-methylguanosine modification require guanosine catabolism? | Knockout and rescue with wild-type or catalytic-dead METTL1 |
| How do point mutations in GDA alter guanine deamination? | CRISPR point mutation knock-in |
| Can tagged PNP be used to track subcellular localization? | Tagged knock-in with fluorescent protein |
| Does overexpression of RNMT alter mRNA cap methylation? | Overexpression in cancer cell lines |
| What is the impact of guanosine catabolism on translation fidelity? | Ribo-seq and polysome profiling in knockout cells |
How to Study the guanosine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metabolomics | Levels of guanosine, guanine, xanthine, urate | Assessing catabolic flux |
| Stable isotope tracing | Flux through purine catabolic pathways | Quantifying guanosine breakdown |
| m7G-seq | 7-methylguanosine modification sites | Mapping modified guanosines on RNA |
| Ribo-seq | Translation efficiency and frameshifting | Studying codon-anticodon interactions |
| Oxidative damage mapping | Abasic sites from oxidized guanosine | RNA damage and repair studies |
| CRISPR knockout | Gene function loss | Testing catabolic enzyme necessity |
| Proteomics | Protein expression and interactions | Identifying catabolic enzyme complexes |
| Imaging | Subcellular localization of enzymes | Tracking PNP or GDA in cells |
Metabolomics and flux analysis
Metabolomics can quantify guanosine, guanine, xanthine, and urate levels to assess guanosine catabolic process. Stable isotope tracing can measure flux through purine catabolic pathways. These methods are essential for linking enzyme activity to cellular purine pools.
RNA modification mapping
Techniques such as m7G-seq and N7-methylguanosine mapping can detect modified guanosines on tRNA and mRNA. These methods help determine how guanosine catabolism affects RNA modification landscapes. Oxidative damage mapping can identify abasic sites from oxidized guanosine.
Translation profiling
Ribo-seq and polysome profiling measure translation efficiency and frameshifting. They are used to study how modified guanosines and their catabolism influence codon-anticodon interactions and protein synthesis.
CRISPR functional genomics
CRISPR knockout, knock-in, and overexpression models enable causal testing of genes involved in guanosine catabolic process. These models can be combined with metabolomics and RNA-seq to dissect pathway function in disease contexts.
How CRISPR Can Be Used to Study GO:0046115 guanosine catabolic process
Knockout
CRISPR knockout of genes such as PNP, GDA, or METTL1 can abolish guanosine catabolic process and reveal its role in purine homeostasis, neuroprotection, and cancer metabolism. Knockout models are ideal for testing whether a candidate gene is required for guanosine breakdown.
Point Mutation
Point mutation knock-in can introduce catalytic-dead or patient-derived mutations in guanosine catabolic enzymes. This approach distinguishes enzymatic activity from scaffolding functions and helps validate specific residues in guanine deamination or phosphorolysis.
Knock-in
Knock-in of tagged versions of PNP, GDA, or RNMT allows tracking of protein localization and interactions. Tagged knock-in models are useful for imaging and proteomic studies of guanosine catabolic process.
Overexpression
Overexpression of catabolic enzymes or modifiers such as METTL1 can increase flux through guanosine catabolic process and modify RNA modification levels. Overexpression models are used to study gain-of-function effects in cancer and neurobiology.
How EDITGENE Supports guanosine catabolic process Research
Researchers studying guanosine catabolic process-related genes often need to determine whether a candidate gene is causally involved in purine turnover, RNA modification, or disease progression. EDITGENE provides CRISPR-based cell model services to enable precise functional interrogation of these pathways.
Contact EDITGENE today to design your custom CRISPR model for guanosine catabolic process research.
Frequently Asked Questions About guanosine catabolic process
What is guanosine catabolic process?
Guanosine catabolic process (GO:0046115) is the set of biochemical reactions that break down guanosine and related guanine-containing nucleosides into purine catabolites.
What genes are involved in guanosine catabolic process?
Key genes include PNP, GDA, XDH, HPRT1, and METTL1, which encode enzymes for guanosine cleavage, guanine deamination, and modified guanosine turnover.
What is the GO ID for guanosine catabolic process?
The GO ID is GO:0046115.
How is guanosine catabolic process regulated?
It is regulated by substrate availability via nucleoside transporters, enzyme expression, and feedback from purine pools, as well as by RNA modification pathways.
Why is guanosine catabolic process important in cancer?
N7-methylguanosine tRNA modification, a guanosine derivative pathway, promotes gastric cancer progression by activating mitochondrial oxidative phosphorylation.
Does guanosine catabolic process affect neuroprotection?
Yes, purine nucleosides such as guanosine have neuroprotective and neuroregenerative effects, and their catabolism controls their availability.
What methods are used to study guanosine catabolic process?
Metabolomics, stable isotope tracing, m7G-seq, Ribo-seq, and CRISPR knockout models are commonly used.
What diseases are linked to guanosine catabolic process?
Cancer, neurodegeneration, and oxidative RNA damage disorders have been linked to guanosine metabolism.
Can CRISPR be used to study guanosine catabolic process?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable causal testing of guanosine catabolic genes.
What are synonyms for guanosine catabolic process?
Synonyms include guanosine breakdown, guanosine catabolism, guanosine degradation, and guanosine phosphorolysis.
Conclusion
Guanosine catabolic process (GO:0046115) is a fundamental purine turnover pathway that controls the availability of guanosine and guanine derivatives for RNA modification, neuroprotection, and energy metabolism. Its dysregulation is linked to cancer progression, neurodegeneration, and oxidative RNA damage. CRISPR-based cell models and multi-omics methods provide powerful tools to dissect this pathway and identify therapeutic targets.
References
- 1. Xu X et al.. 2025. N(7)-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation.. Cancer Lett 615:217566 PMID: 39965707
- 2. Kimbrough EM et al.. 2025. An RNA modification prevents extended codon-anticodon interactions from facilitating +1 frameshifting.. Nat Commun 16(1):7392 PMID: 40789848
- 3. Tomikawa C. 2018. 7-Methylguanosine Modifications in Transfer RNA (tRNA).. Int J Mol Sci 19(12) PMID: 30562954
- 4. Ribeiro FF et al.. 2016. Purine nucleosides in neuroregeneration and neuroprotection.. Neuropharmacology 104:226-42 PMID: 26577017
- 5. Rollenhagen C et al.. 2006. Nuclear import of spliceosomal snRNPs.. Can J Physiol Pharmacol 84(3-4):367-76 PMID: 16902583
- 6. Cowling VH. 2009. Regulation of mRNA cap methylation.. Biochem J 425(2):295-302 PMID: 20025612
- 8. Weber M et al.. 2025. Mapping of HOCl-oxidized RNA identifies abasic sites as major damage and oxidation product of oxo(8)G.. Nat Commun 16(1):10251 PMID: 41271707
